138 related articles for article (PubMed ID: 26294099)
21. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
[TBL] [Abstract][Full Text] [Related]
23. Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.
Beg S; Siraj AK; Prabhakaran S; Jehan Z; Ajarim D; Al-Dayel F; Tulbah A; Al-Kuraya KS
Breast Cancer Res Treat; 2015 Jun; 151(3):541-53. PubMed ID: 25981902
[TBL] [Abstract][Full Text] [Related]
24. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
26. Somatic Mutations of PI3K in Early and Advanced Gallbladder Cancer: Additional Options for an Orphan Cancer.
Roa I; Garcia H; Game A; de Toro G; de Aretxabala X; Javle M
J Mol Diagn; 2016 May; 18(3):388-394. PubMed ID: 26947513
[TBL] [Abstract][Full Text] [Related]
27. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.
Gu X; Li B; Jiang M; Fang M; Ji J; Wang A; Wang M; Jiang X; Gao C
Oncotarget; 2015 Aug; 6(24):20661-71. PubMed ID: 25970782
[TBL] [Abstract][Full Text] [Related]
28. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V; M N
Tumour Biol; 2014 Sep; 35(9):9241-6. PubMed ID: 24935470
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
30. Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer.
Zhang M; Gong W; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Jiang A; Ma F; Quan Z
Mol Med Rep; 2015 May; 11(5):3539-46. PubMed ID: 25573292
[TBL] [Abstract][Full Text] [Related]
31. DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies.
Ren F; Yang ZL; Tan X; Liu D; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Appl Immunohistochem Mol Morphol; 2014; 22(10):741-7. PubMed ID: 25046228
[TBL] [Abstract][Full Text] [Related]
32. Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer.
Bohn BA; Mina S; Krohn A; Simon R; Kluth M; Harasimowicz S; Quaas A; Bockhorn M; Izbicki JR; Sauter G; Marx A; Stahl PR
Hum Pathol; 2013 Aug; 44(8):1524-33. PubMed ID: 23465274
[TBL] [Abstract][Full Text] [Related]
33. ERCC1 (excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor.
Roa I; de Aretxabala X; Lantadilla S; Munoz S
Histol Histopathol; 2011 Jan; 26(1):37-43. PubMed ID: 21117025
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: an unfavorable and independent prognostic factor.
Sun W; Fan YZ; Xi H; Lu XS; Ye C; Zhang JT
Oncol Rep; 2011 Nov; 26(5):1133-42. PubMed ID: 21750868
[TBL] [Abstract][Full Text] [Related]
35. CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.
Ding Q; Li M; Wu X; Zhang L; Wu W; Ding Q; Weng H; Wang X; Liu Y
Tumour Biol; 2015 Jan; 36(1):193-8. PubMed ID: 25227665
[TBL] [Abstract][Full Text] [Related]
36. Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.
Taskin OC; Akkas G; Memis B; Seven IE; Basturk O; Jang KT; Roa JC; Araya JC; Bellolio E; Losada H; Sarmiento J; Balci S; Pehlivanoglu B; Reid MD; Koshiol J; Adsay V
Virchows Arch; 2019 Jul; 475(1):59-66. PubMed ID: 31177317
[TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment for advanced gallbladder cancer].
Yan L; Zhou Y; Jin L
Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):277-8. PubMed ID: 10374560
[TBL] [Abstract][Full Text] [Related]
38. Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.
Sim J; Kim Y; Kim H; Bang S; Jee S; Park S; Shin SJ; Jang K
In Vivo; 2020; 34(1):125-132. PubMed ID: 31882471
[TBL] [Abstract][Full Text] [Related]
39. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
[TBL] [Abstract][Full Text] [Related]
40. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
